Bayer gets nod to market Kerendia for heart failure treatment

Bayer has secured approval in India for its therapy Kerendia to treat heart failure. This drug, finerenone, is already used for chronic kidney disease linked to type 2 diabetes. The expanded use targets heart failure types that have lacked effective treatments. Finerenone now addresses major health issues in India, including cardiovascular and kidney diseases.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/r75jNz8
via IFTTT